Like all living organisms, cells ingest foreign bodies, but not always as nutrients. Ingestion is also used to eliminate pathogens such as bacteria or harmful cellular waste. This cell function, known as phagocytosis, is vital, notably to the immune and inflammatory response.
Target enveloping :Once cellular waste are recognized and anchored on membrane;; the assembly of actin filaments starts. The membrane progressively engulfs the waste; what needs a supply of membranes from various internal cellular compartments.When the membrane folds fuse;; the waste is completely ingested by the cell and rendered harmless
Target cells ingested by white blood cells : On picture A;; the white blood cell (big cell) recognised some target cells (little white spheres) to eliminate and anchored them on its membrane. 50 minutes later (picture B);; target cells have been ingested. On pictures C;;D;; and E the white blood cell expresses a mutant type of ARF6 blocked in inactive position. On picture C;; the white blood cell recognised other white blood cells to eliminate and anchored them on its membrane. On picture D;; taken 50 minutes later;; target cells are still anchored on the white blood cells membrane and havent been ingested. On picture E;; the extension of the membrane starts but stops soon. Absorption doesnt occur.
CNRS research scientists at the Institut Curie have recently clarified the function of the protein ARF6 in phagocytosis, a mechanism which is still poorly understood. When ARF6 is lacking, the cells can eliminate neither waste nor pathogenic microorganisms. This breakdown in the "cell cleaning" system may then result in major dysfunction (infection, inflammation) or even compromise the organisms integrity (risk of tumor).
These results are presented in the 23 June 2003 issue of Journal of Cell Biology.
In the case of chronic infection or inflammation, the bodys equilibrium is compromised and there is even the risk of the development of tumors. In particular, a link has been established between Helicobacter pylori infection and the development of gastric cancer, but the mechanisms brought into play in this model of oncogenesis remain poorly understood.
A very recent American publication has provided a clue to the putative link between chronic inflammation and the appearance of cancer: in mice whose phagocytic and immune functions are deficient, chronic infections lead to the growth of spontaneous tumors when the animals are not treated with antibiotics. This is new proof of the importance of phagocytosis, for good functioning of the body.
Envelop then degrade
When "cleaning cells" recognize a target to be eliminated, using their membrane receptors, they anchor it to the membrane. Phagocytosis then starts with the formation of membrane folds, a sort of envelope which progressively engulfs the target until it is internalized within the cell.
The gradual formation of a membrane requires reorganization of actin filaments, the "muscles" of the cell, and remodeling of the membrane. The assembly (polymerization) of actin filaments "pushes" the membrane around the cellular waste by a process analogous to that seen in cell motility (see "Further information on").
To enlarge the surface area of the membrane so as to allow enfolding of cellular waste, a supply of membranes from various internal cellular compartments is indispensable. When the waste is fully enveloped, the membrane folds fuse thereby completely ingesting the waste and rendering it harmless. The waste is then conveyed to vesicles where it is degraded. At this stage antigens are processed and once transported to the surface of cells, will trigger the immune response (acquired immunity).
At the Institut Curie, Philippe Chavriers "Membrane and cytoskeleton dynamics" team is studying the reorganization of the membrane and of the cytoskeleton during phagocytosis. It is focusing in particular on the protein ARF6, which is thought to play a part in phagocytosis and in cell motility, and whose precise function remains to be elucidated.
ARF6 "delivers" membranes
Like many proteins, ARF6 works as a "biological switch" flicking successively between the inactive and active states, during which it fulfils its functions. In this new work, Florence Niedergang of Philippe Chavriers team has demonstrated for the first time that ARF6 is activated during phagocytosis, at the start of the process, suggesting that it plays a part in the early stages of the engulfing of waste.
To study this hypothesis further, researchers at the Institut Curie studied phagocytosis by scanning electron microscopy in cells where ARF6 is blocked in the inactive position. They found that the extension of the membrane around the waste is soon stopped. Furthermore, they noted that the interruption was not due to blockade of actin polymerization but to defective delivery of membranes from the intracellular compartments.
ARF6 therefore plays a crucial role in the delivery of membranes during phagocytosis.
As phagocytosis and cell motility share several features (see below), ARF6 could also be indispensable to cell motility and may be involved in the formation of metastases. The presence of metastases renders cancer treatment more problematical, and so it is important to identify the proteins that participate in this process and which could in time serve as targets for new therapies.
The work of Philippe Chavrier and his team at the Institut Curie therefore provides fundamental information on the mechanisms of phagocytosis, while providing a glimpse of new leads in the understanding of cancerous processes.
Catherine Goupillon | Institut Curie
Biophysicists reveal how optogenetic tool works
29.05.2020 | Moscow Institute of Physics and Technology
Mapping immune cells in brain tumors
29.05.2020 | University of Zurich
In living cells, enzymes drive biochemical metabolic processes enabling reactions to take place efficiently. It is this very ability which allows them to be used as catalysts in biotechnology, for example to create chemical products such as pharmaceutics. Researchers now identified an enzyme that, when illuminated with blue light, becomes catalytically active and initiates a reaction that was previously unknown in enzymatics. The study was published in "Nature Communications".
Enzymes: they are the central drivers for biochemical metabolic processes in every living cell, enabling reactions to take place efficiently. It is this very...
Early detection of tumors is extremely important in treating cancer. A new technique developed by researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from normal tissue. The work is published May 25 in the journal Nature Nanotechnology.
researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from...
Microelectronics as a key technology enables numerous innovations in the field of intelligent medical technology. The Fraunhofer Institute for Biomedical Engineering IBMT coordinates the BMBF cooperative project "I-call" realizing the first electronic system for ultrasound-based, safe and interference-resistant data transmission between implants in the human body.
When microelectronic systems are used for medical applications, they have to meet high requirements in terms of biocompatibility, reliability, energy...
Thomas Heine, Professor of Theoretical Chemistry at TU Dresden, together with his team, first predicted a topological 2D polymer in 2019. Only one year later, an international team led by Italian researchers was able to synthesize these materials and experimentally prove their topological properties. For the renowned journal Nature Materials, this was the occasion to invite Thomas Heine to a News and Views article, which was published this week. Under the title "Making 2D Topological Polymers a reality" Prof. Heine describes how his theory became a reality.
Ultrathin materials are extremely interesting as building blocks for next generation nano electronic devices, as it is much easier to make circuits and other...
Scientists took a leukocyte as the blueprint and developed a microrobot that has the size, shape and moving capabilities of a white blood cell. Simulating a blood vessel in a laboratory setting, they succeeded in magnetically navigating the ball-shaped microroller through this dynamic and dense environment. The drug-delivery vehicle withstood the simulated blood flow, pushing the developments in targeted drug delivery a step further: inside the body, there is no better access route to all tissues and organs than the circulatory system. A robot that could actually travel through this finely woven web would revolutionize the minimally-invasive treatment of illnesses.
A team of scientists from the Max Planck Institute for Intelligent Systems (MPI-IS) in Stuttgart invented a tiny microrobot that resembles a white blood cell...
19.05.2020 | Event News
07.04.2020 | Event News
06.04.2020 | Event News
29.05.2020 | Materials Sciences
29.05.2020 | Materials Sciences
29.05.2020 | Power and Electrical Engineering